Supplementary Table 3.docx (25.8 kB)
Supplementary Table 3: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study
dataset
posted on 2021-11-18, 09:13 authored by Shin-ichi Konno, Takuya Nikaido, John D Markman, Makoto Ohta, Toshiya Machida, Naoki Isogawa, Hiroki Yoshimatsu, Lars Viktrup, Mark T Brown, Christine R West, Kenneth M Verburg
|